HKBU-led research team develops novel antiviral targeted drug for nasopharyngeal cancer
(Hong Kong Baptist University) A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumors caused by the virus. It is the first known agent to successfully target the virus and disturb its latency in tumor cells in this way. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2020 Category: Cancer & Oncology Source Type: news

Inherent Flaws in COVID-19 Testing Mean Some of Those Infected Don ’t Get the Treatment They Need
In late February, several weeks before the coronavirus outbreak shut down American cities and rose to the level of a national crisis, Kerri Rawson began to feel sick. “I was hit out of nowhere with what feels like the flu at first,” says Rawson, who also has asthma and takes cardiac medication for high-blood pressure. “You’re fine, and then all of a sudden you have a fever below 100°F and chest congestion.” Rawson is a 41-year-old writer and mother of two in Florida. (You may recognize her name from her 2019 memoir, about growing up as the daughter of a serial killer.) Her fever lasted for...
Source: TIME: Health - May 8, 2020 Category: Consumer Health News Authors: Zach Schonfeld Tags: Uncategorized COVID-19 feature Source Type: news

Whitehorse man says Stage 4 cancer could have been avoided if he had family doctor
A man in Whitehorse says he believes his nasopharyngeal cancer was first detected at advanced Stage 4 because he didn't have a family doctor. (Source: CBC | Health)
Source: CBC | Health - January 6, 2020 Category: Consumer Health News Tags: News/Canada/North Source Type: news

Fewer Cases of Radiation-Induced Xerostomia Found With Acupuncture
TUESDAY, Dec. 10, 2019 -- Acupuncture results in significantly fewer and less severe symptoms of radiation-induced xerostomia (RIX) among patients with oropharyngeal or nasopharyngeal carcinoma, according to a study published online Dec. 6 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 10, 2019 Category: Pharmaceuticals Source Type: news

Living With Cancer: Nasopharyngeal carcinoma
Nasopharyngeal carcinomaNasopharyngeal carcinoma is cancer that occurs in the nasopharynx, which is located behind your nose and above the back of your throat. This type of cancer is rare in the U.S. It occurs much more frequently in other parts of the world, especially Southeast Asia. It can be difficult to detect early because the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 3, 2019 Category: Databases & Libraries Source Type: news

' Big Jump' in Survival in Advanced Nasopharyngeal Cancer'Big Jump' in Survival in Advanced Nasopharyngeal Cancer
Gemcitabine/cisplatin induction chemo significantly improved outcomes in locally advanced nasopharyngeal carcinoma in a trial conducted in China.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 20, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Nail technicians are up to '100 TIMES more at risk of cancer'
A study of six nail salons in Colorado found their air contained formaldehyde at levels beyond what is deemed safe to avoid squamous cell carcinoma, nasopharyngeal cancer or Hodgkin's lymphoma. (Source: the Mail online | Health)
Source: the Mail online | Health - May 13, 2019 Category: Consumer Health News Source Type: news

Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial
With the Stanford Cancer Institute joining as a clinical trial partner, Tessa's Phase III trial for nose cancer (nasopharyngeal cancer) is now widely accessible across multiple locations in the U.S. The therapy is based on Tessa's Virus-Specific T cell ... Biopharmaceuticals, Oncology Tessa Therapeutics, nasopharyngeal cancer, T cell immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news

UCLA study describes structure of tumor herpes virus associated with Kaposi ’s sarcoma
UCLA researchers have provided the first description of the structure of the herpes virus associated with Kaposi ’s sarcoma, a type of cancer.The discovery answers important questions about how the virus spreads and provides a potential roadmap for the development of antiviral drugs to combat both that virus and the more common Epstein-Barr virus, which is present in more than 90 percent of the adult population and is believed to have a nearly identical structure.In the study, published in the journal  Nature, the UCLA team showed in the laboratory that an inhibitor could be developed to break down the herpes virus. Kap...
Source: UCLA Newsroom: Health Sciences - January 20, 2018 Category: Universities & Medical Training Source Type: news

GERD Linked to Upper Aerodigestive Tract Cancers
In elderly, tied to higher odds of malignancy in larynx, hypopharynx, oropharynx, nasopharynx (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 26, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, ENT, Pathology, Journal, Source Type: news

Nasopharyngeal Cancer in Children
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 7, 2017 Category: General Medicine Source Type: news

Adding Tislelizumab to Chemo Slows Advanced Nasopharyngeal Cancer
Progression - free survival prolonged with tislelizumab + chemotherapy versus chemotherapy alone in recurrent/metastatic NPC (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 12, 2017 Category: Cancer & Oncology Tags: Oncology, ENT, Pharmacy, Conference News, Source Type: news

Unrelenting NHS pressure affecting cancer care, say GPs and nurses
Half of GPs and primary care nurses not confident NHS workforce can provide adequate care Related items fromOnMedica Nasopharyngeal carcinoma and sinus cancer UK spends 20% less on cancer treatment than rest of EU Fifteen local NHS transformation projects to get cash boost The genetics of breast cancer Meeting cancer promises and more – a new model for NHS diagnostics? (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 8, 2017 Category: UK Health Source Type: news

Nutlin-3, a p53-Mdm2 antagonist for nasopharyngeal carcinoma treatment
(Bentham Science Publishers) Nasopharyngeal carcinoma (NPC) is a form of head and neck cancer that is highly prevalent among men in the populations of Southern China and Southeast Asia. This review will discuss the potential use of Nutlin-3 as a p53-activating drug and the future directions of its clinical research for NPC treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 23, 2017 Category: Cancer & Oncology Source Type: news

Liquid Biopsy Passes Test for Nasopharyngeal Cancer (CME/CE)
(MedPage Today) -- Impressive sensitivity and specificity in Chinese study (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 15, 2017 Category: Hematology Source Type: news